DETERMINATION OF PROTECTIVE LEVELS OF MATERNAL ANTIBODY AGAINST EARLYONSET INVASIVE GROUP B STREPTOCOCCAL DISEASE IN NEONATES
NIH GUIDE, Volume 23, Number 8, February 25, 1994
RFP AVAILABLE: NICHD-DESPR-94-06
P.T. 34
Keywords:
Immunotherapy
Infectious Diseases/Agents
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development (NICHD)
plans to conduct a study that will recruit two groups of infants <7
days of age: infants who have developed invasive GBS (Type Ia, Ib,
II and III) disease ("cases"), and infants who have not developed
early onset GBS despite being born to GBS-colonized mothers
("controls"). GBS disease will be defined as an infection associated
with isolation of GBS from normally sterile sites, such as
cerebrospinal fluid and blood. A total of 240 cases and 960 controls
will be recruited from participating hospitals over a period of two
years. Cases will be identified by active laboratory-based
surveillance, and controls will be identified through a systematic
culturing of about five percent of parturient mothers in the
participating hospitals. To be eligible, both cases and controls
must be singleton births of at least 34 weeks' gestation, born to
mothers who have not received antibiotic treatment during pregnancy.
This Request for Proposals (RFP) for the detection of GBS is a new
acquisition. The release of the RFP will be on or about March 1, 1994
and proposals will be due 60 days thereafter.
INQUIRIES
A short-form version of the RFP will be provided first, which
includes only the Statement of Work and Evaluation Criteria to be
used for selection of the awardee. After examining this, a full-text
version of the RFP must be requested, in writing, for those
organizations interested in responding. Those organizations desiring
a copy of the above short-form RFP may send their written request to:
Mrs. Lynn Salo
Office of Grants and Contracts
National Institute of Child Health and Human Development
6100 Building, Room 7A07
Bethesda, MD 20892
All requests must cite the RFP number above and include two self-
addressed mailing labels for the short-form and complete RFP. All
sources who consider themselves qualified are encouraged to submit a
proposal. This announcement does not commit the Government to
awarding a contract.
.
Return to NIH Guide Main Index
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||